Quarterly report [Sections 13 or 15(d)]

Statements of Cash Flows (Unaudited)

v3.26.1
Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities:      
Net loss $ (1,847,706) $ (2,303,587)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Stock-based compensation 43,278 37,189  
Increase (decrease) in cash resulting from changes in:      
Prepaid expenses and other current assets (85,431) 86,579  
Inventory (93,091)  
Accounts payable (51,128) 102,064  
Accrued and other current liabilities (445,640) 143,689  
Net cash used in operating activities (2,479,718) (1,934,066) $ (7,800,000)
Cash flows from financing activities:      
Proceeds from issuance of Common Stock from ATM sales, net of issuance costs 1,994,374  
Proceeds from issuance of Common Stock, pre-funded warrants, and warrants, net of issuance costs 8,541,282  
Proceeds from exercise of pre-funded warrants 977  
Payment of issuance costs (91,352) (50,495)  
Net cash provided by financing activities 1,903,022 8,491,764  
Net increase (decrease) in Cash and cash equivalents (576,696) 6,557,698  
Cash and cash equivalents at beginning of period 7,521,978 3,161,570 3,161,570
Cash and cash equivalents at end of period 6,945,282 9,719,268 $ 7,521,978
Non-cash financing activities:      
Issuance Common Stock upon exercise of pre-funded warrants 54  
ATM issuance costs in accrued expenses 323  
January 2025 PIPE issuance costs in accounts payable 79,102  
March 2025 Warrant Inducement issuance costs in accounts payable $ 456,631